Ashley Cheree Woods, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity
Clinical Lymphoma Myeloma and Leukemia
Date: 06 2023
https://pubmed.ncbi.nlm.nih.gov/37076368/

Differentiation Syndrome in Acute Leukemia: APL and Beyond
Cancers
Date: 09 2023
https://www.mdpi.com/2072-6694/15/19/4767

FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Clinical Cancer Research
Date: 11 2023
https://pubmed.ncbi.nlm.nih.gov/38010220/